Detalhe da pesquisa
1.
A Randomised Clinical Trial of the Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087).
medRxiv
; 2024 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38260276
2.
Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global region.
J Glob Health
; 13: 06020, 2023 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37352144
3.
Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition: Results From the Phase 2b Antibody-Mediated Prevention Randomized Trials.
J Acquir Immune Defic Syndr
; 89(4): 405-413, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34923559
4.
Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody.
J Acquir Immune Defic Syndr
; 87(1): 671-679, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587505
5.
A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings.
J Acquir Immune Defic Syndr
; 87(1): 680-687, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587510
6.
HIV vaccine-induced sero-reactivity: a challenge for trial participants, researchers, and physicians.
Vaccine
; 33(10): 1243-9, 2015 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25649349
7.
Recommendations for the follow-up of study participants with breakthrough HIV infections during HIV/AIDS biomedical prevention studies.
AIDS
; 27(7): 1119-28, 2013 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23262497